Literature DB >> 19159617

Role of E-cadherin N-glycosylation profile in a mammary tumor model.

Salomé S Pinho1, Hugo Osório, Mihai Nita-Lazar, Joana Gomes, Célia Lopes, Fátima Gärtner, Celso A Reis.   

Abstract

Modifications in cell surface glycosylation affecting cell adhesion are common characteristics of transformed cells. This study characterizes the N-glycosylation profile of E-cadherin in models of canine mammary gland adenoma and carcinoma evaluating the importance of these glycosylation modifications in the malignant phenotype. Our results show that the pattern of E-cadherin N-glycosylation in mammary carcinoma is characterized by highly branched N-glycans, increase in sialylation and an expression of few high mannose structures. Detailed mass spectrometry analysis demonstrated a new N-glycosylation site containing a potential complex type N-glycan in E-cadherin from a mammary carcinoma cell line. Our study demonstrates the importance of E-cadherin N-glycans in the process of tumor development and in the transformation to the malignant phenotype.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19159617     DOI: 10.1016/j.bbrc.2009.01.024

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  27 in total

Review 1.  Glycan changes: cancer metastasis and anti-cancer vaccines.

Authors:  Min Li; Lujun Song; Xinyu Qin
Journal:  J Biosci       Date:  2010-12       Impact factor: 1.826

2.  A Computational Model for Kinetic Studies of Cadherin Binding and Clustering.

Authors:  Jiawen Chen; Jillian Newhall; Zhong-Ru Xie; Deborah Leckband; Yinghao Wu
Journal:  Biophys J       Date:  2016-10-04       Impact factor: 4.033

3.  β-Galactoside α2,6-sialyltranferase 1 promotes transforming growth factor-β-mediated epithelial-mesenchymal transition.

Authors:  Jishun Lu; Tomoya Isaji; Sanghun Im; Tomohiko Fukuda; Noritaka Hashii; Daisuke Takakura; Nana Kawasaki; Jianguo Gu
Journal:  J Biol Chem       Date:  2014-10-24       Impact factor: 5.157

Review 4.  Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2009-2010.

Authors:  David J Harvey
Journal:  Mass Spectrom Rev       Date:  2014-05-26       Impact factor: 10.946

5.  Preventing E-cadherin aberrant N-glycosylation at Asn-554 improves its critical function in gastric cancer.

Authors:  S Carvalho; T A Catarino; A M Dias; M Kato; A Almeida; B Hessling; J Figueiredo; F Gärtner; J M Sanches; T Ruppert; E Miyoshi; M Pierce; F Carneiro; D Kolarich; R Seruca; Y Yamaguchi; N Taniguchi; C A Reis; S S Pinho
Journal:  Oncogene       Date:  2015-07-20       Impact factor: 9.867

6.  Roles of N-acetylglucosaminyltransferase III in epithelial-to-mesenchymal transition induced by transforming growth factor β1 (TGF-β1) in epithelial cell lines.

Authors:  Qingsong Xu; Tomoya Isaji; Yingying Lu; Wei Gu; Madoka Kondo; Tomohiko Fukuda; Yuguang Du; Jianguo Gu
Journal:  J Biol Chem       Date:  2012-03-26       Impact factor: 5.157

7.  CD133, Trop-2 and alpha2beta1 integrin surface receptors as markers of putative human prostate cancer stem cells.

Authors:  Marco Trerotola; Swati Rathore; Hira Lal Goel; Jing Li; Saverio Alberti; Mauro Piantelli; Dave Adams; Zhong Jiang; Lucia R Languino
Journal:  Am J Transl Res       Date:  2010-03-15       Impact factor: 4.060

Review 8.  Modulation of E-cadherin function and dysfunction by N-glycosylation.

Authors:  Salomé S Pinho; Raquel Seruca; Fátima Gärtner; Yoshiki Yamaguchi; Jianguo Gu; Naoyuki Taniguchi; Celso A Reis
Journal:  Cell Mol Life Sci       Date:  2010-11-23       Impact factor: 9.261

Review 9.  Potential roles of N-glycosylation in cell adhesion.

Authors:  Jianguo Gu; Tomoya Isaji; Qingsong Xu; Yoshinobu Kariya; Wei Gu; Tomohiko Fukuda; Yuguang Du
Journal:  Glycoconj J       Date:  2012-05-08       Impact factor: 2.916

10.  Cadherin cell adhesion system in canine mammary cancer: a review.

Authors:  Adelina Gama; Fernando Schmitt
Journal:  Vet Med Int       Date:  2012-08-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.